With an exceptional blend of contemporary clinical expertise, extensive research proficiency and a commitment to evidence- based medicine, Dr Khin has made contributions in the realm of healthcare and clinical research. Having experience in Early Phase – 1 to Phase – 4 clinical studies, she has garnered a wealth of experience in the review and analysis of critical safety data thus playing a pivotal role in driving informed clinical decisions.

Additionally, Dr Khin’s Proficiency in advanced data analysis, encompassing sophisticated methodologies like Randomized Controlled Clinical Trial data analysis, propensity score matching and real – world data interpretation has enabled the development of innovative prognostic models and risk score algorithms.